Hiring in life sciences? Share your open positions with our professional community. Read more Close

Your cookie settings

This site uses cookies. Some cookies are essential to make the site work and others help us to improve our services. Read more about cookies in our Privacy policy.

Choose your cookie preferences:

Advertisement

Rusfertide for Polycythemia Vera: Incremental Benefit Assessment.

Created on 18 Oct 2026

Authors

Ayalew Tefferi, Naseema Gangat, Paola Guglielmelli, Alessandro M Vannucchi, Tiziano Barbui

Published in

American journal of hematology. Oct 17, 2026. Epub Oct 17, 2026.

Abstract

Rusfertide mechanism of action and clinical trial results in polycythemia vera.

PMID:
42891571
Bibliographic data and abstract were imported from PubMed on 18 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Sign in to post a review. Add review
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Do you recommend this? Please sign in. Yes No

Recommended

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement